Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |